ATE58521T1 - Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel. - Google Patents

Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.

Info

Publication number
ATE58521T1
ATE58521T1 AT87113510T AT87113510T ATE58521T1 AT E58521 T1 ATE58521 T1 AT E58521T1 AT 87113510 T AT87113510 T AT 87113510T AT 87113510 T AT87113510 T AT 87113510T AT E58521 T1 ATE58521 T1 AT E58521T1
Authority
AT
Austria
Prior art keywords
lysine salt
medicines containing
biphenylacetic acid
eye
eye medicines
Prior art date
Application number
AT87113510T
Other languages
English (en)
Inventor
Giuseppe Benanti
Original Assignee
Sifi Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sifi Spa filed Critical Sifi Spa
Application granted granted Critical
Publication of ATE58521T1 publication Critical patent/ATE58521T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AT87113510T 1986-09-26 1987-09-16 Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel. ATE58521T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21828/86A IT1197289B (it) 1986-09-26 1986-09-26 Sale di lisina dell'acido 4-bifenilacetico e sue composizioni oftalmiche
EP87113510A EP0261565B1 (de) 1986-09-26 1987-09-16 Lysinsalz der 4-Biphenylessigsäure und es enthaltende Augenheilmittel

Publications (1)

Publication Number Publication Date
ATE58521T1 true ATE58521T1 (de) 1990-12-15

Family

ID=11187439

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87113510T ATE58521T1 (de) 1986-09-26 1987-09-16 Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.

Country Status (6)

Country Link
US (1) US4797423A (de)
EP (1) EP0261565B1 (de)
JP (1) JP2530176B2 (de)
AT (1) ATE58521T1 (de)
DE (1) DE3766334D1 (de)
IT (1) IT1197289B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
IT1233836B (it) * 1988-01-13 1992-04-21 Euroresearch Srl Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato.
US6078664A (en) 1996-12-20 2000-06-20 Moskowitz; Scott A. Z-transform implementation of digital watermarks
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624142A (en) * 1964-09-10 1971-11-30 Merck & Co Inc Substituted biphenyl acetic acid derivatives
NL6717184A (de) * 1967-12-16 1969-06-18 Stamicarbon
DE2205442A1 (de) * 1972-02-03 1973-08-09 Josef Dipl Chem Dr Rer N Klosa Lysinsalz der p-chlorphenoxyisobuttersaeure, deren herstellung, zubereitung und verwendung
US3784704A (en) * 1972-10-13 1974-01-08 American Cyanamid Co Compositions of 4-biphenyl acetic acid and method of use
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US3991206A (en) * 1976-01-15 1976-11-09 American Cyanamid Company Alleviation of eye inflammation by topical application of p-biphenylacetic acid
FR2379511A1 (fr) * 1977-02-02 1978-09-01 Hexachimie Sel de lysine de l'acide a-methyl (isopropyl-2 indanyl-5) acetique
US4189499A (en) * 1977-03-16 1980-02-19 Biochefarm S.A. Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
DE2711964A1 (de) * 1977-03-18 1978-09-21 Biochefarm Lysin-4-allyloxy-3-chlorphenylacetat, verfahren zu seiner herstellung und es enthaltende pharmazeutische zubereitung
DE3011437A1 (de) * 1980-03-25 1981-10-01 Hrvoje Dr. Zagreb Krnjevic Pharmazeutisches mittel zur heilung von entzuendlichen und/oder degenerativen und/oder atrophischen schleimhauterkrankungen
DE3438455A1 (de) * 1984-10-19 1986-06-26 Institut Dr. Ziegler, Bettingen L-lysin- und l-histidinpyruvat

Also Published As

Publication number Publication date
IT8621828A0 (it) 1986-09-26
IT8621828A1 (it) 1988-03-26
IT1197289B (it) 1988-11-30
US4797423A (en) 1989-01-10
JP2530176B2 (ja) 1996-09-04
EP0261565A1 (de) 1988-03-30
JPS63101352A (ja) 1988-05-06
DE3766334D1 (de) 1991-01-03
EP0261565B1 (de) 1990-11-22

Similar Documents

Publication Publication Date Title
NO180719C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive A-nor-steroid-3-carboxylsyrederivater
NO170480C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO864425L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO172343C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater
NO865204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzosyre- og benzosyreester-derivater.
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
ZA866973B (en) Novel enolamides,pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascade
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
NO173319C (no) Anvendelse av et olefyrin for p}visning av tumorer
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
PT92228A (pt) Processo para a preparacao de uma formulacao oral liquida, contendo diclofenac
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
IT8621112A0 (it) Derivati dell'acido tiazolidin-4-carbossilico adattivita' farmaceutica.
NO171108C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
NO168176C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, substituerte benzamider
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties